Abstract
Lithium use for bipolar disorder has decreased in the United States. We aimed at studying lithium prescription in Spain from 1985 to 2003. Prescription data, expressed in daily defined dose per 1000 inhabitants per day, were obtained. Lithium prescription increased uninterruptedly from 0.21 to 0.79 DID. The psychiatric reform in Spain and a broader definition of BD during the last decades are possible explanations for this rise.
Original language | English |
---|---|
Pages (from-to) | 273-276 |
Number of pages | 4 |
Journal | Journal of Affective Disorders |
Volume | 91 |
Issue number | 2-3 |
DOIs | |
Publication status | Published - 1 Apr 2006 |
Keywords
- Bipolar disorder
- Drug utilization
- Drug utilization/trends
- Lithium
- Pharmacoepidemiology